City Therapeutics Inc. CTY · SEC Filings

website

City Therapeutics, Inc. is a biotechnology company specializing in next-generation RNA interference ...

Price18.67

Market Cap965.63 M

Float11.11 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

News

TYPE

HEADLINE

FILED AT

8-K

City Therapeutics, Inc. Files Amended and Restated Certificate of Incorporation and Bylaws in Connection with IPO

Oct 19, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B4

Form 424B4 - Prospectus [Rule 424(b)(4)]

Oct 16, 2026

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Oct 16, 2026

S-1MEF

OFFERING

Oct 15, 2026

8-A12B

Form 8-A12B - Registration of securities [Section 12(b)]

Oct 13, 2026

S-1/A

OFFERING - IPO EFFECTIVE, DATED 2026-10-15

Oct 9, 2026

S-1

Form S-1 - General form for registration of securities under the Securities Act of 1933

Sep 24, 2026

DRS/A

Form DRS/A - Draft Registration Statement: [Amend]

Aug 21, 2026

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G

FMR LLC (Filed by)

Nov 6, 2026

SCHEDULE 13D

ARCH Venture Fund XII, L.P. (Filed by)

Oct 26, 2026

SCHEDULE 13G

VIKING GLOBAL INVESTORS LP (Filed by)

Oct 26, 2026

SCHEDULE 13G

Invus Global Management, LLC (Filed by)

Oct 22, 2026

CRANDELL KEITH (Reporting)

Oct 19, 2026

NELSEN ROBERT (Reporting)

Oct 19, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Oct 16, 2026